CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Clinical and Electrophysiologic Improvement in Lambert-Eaton Syndrome with Intravenous Immunoglobulin Therapy
Neurol 42:1422-1423, Bird,S.J., 1992
Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
Inflammatory Muscle Diseases
NEJM 372:1734-1747, Dalakas, M.C., 2015
Inflammatory Myopathies with Anti-Ku Antibodies
Medicine 91:95-102, Rigolet,A.,et al, 2012
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991
Inclusion Body Myositis, Observations in 40 Patients
Brain 112:727-747, Lotz,B.P.,et al, 1989
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Clin Characteristics, Course, & Diag Criteria
Arch Neurol 46:878-884, Barohn,R.J.,et al, 1989
The Lambert-Eaton Myasthenic Syndrome, A Review of 50 Cases
Brain 111, 577-5961988., O'Neill,J.H.,et al, 1988
Myasthenia Gravis & Myasthenic Syndromes
Ann Neurol 16:519-534, Engel,A.G., 1984
Eosinophilic Polymyositis
Ann Neurol 1:65, Layzer,R.B.,et al, 1977